Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Evidence of antitumor efficacy found for PDX in NSCLC

July 11, 2003

IDM exercises option to license cancer epitopes from Epimmune

July 11, 2003

Recent Merck patents cover pyrimidinone KSP inhibitors

July 10, 2003

Trichostatin A potentiates the proapoptotic effects of biomodulators on hepatocellular carcinoma

July 10, 2003

Transient antitumor effects of tipifarnib in hematological malignancies

July 10, 2003

First preclinical data supporting AP-23464 as an alternative to Gleevec

July 9, 2003

PI-88 achieves primary efficacy endpoint in multiple myeloma trial

July 9, 2003

Antitumor Cdc25 phosphatase inhibitors designed at Maxia

July 9, 2003

Good tolerability profile reported for IMC-1C11 in patients with metastatic colorectal cancer

July 8, 2003

Phase II trial of GTI-2040 in AML cleared by FDA

July 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...